Top Markets
#1 Siren Siren +44.38%
#2 Full Moon Full Moon +19.74%
#3 Wrapped NXM Wrapped NXM +12.31%
#4 VVS Finance VVS Finance +11.53%
#5 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +10.95%
#6 Seeker Seeker +9.74%
#7 Helium Helium +9.54%
#8 Cryptopia Cryptopia +9.26%
#9 Zora Zora +7.54%
#10 Axelar Axelar +6.97%
Coin of the day
Siren Siren
Configurações
Idioma
PORTUGUêS
Moeda
USD
Tema
Cybin Inc. Common Stock Cybin Inc. Common Stock

Cybin Inc. Common Stock

HELP
Classificação em ações #11953
Cybin Inc. functions as a biopharmaceutical company currently in its clinical... Cybin Inc. functions as a biopharmaceutical company currently in its clinical development phase, concentrating on the advancement of novel therapeutic agents derived from psychedelic compounds. Its research pipeline includes CYB003, a deuterated psilocybin analog under investigation for major depressive disorder, and CYB004, a deuterated DMT compound being developed to address generalized anxiety disorder.
Preço da ação
$10.30
Última sincronização: 2026-08-11
Valor de mercado
$638.32M
Variação (1 dia)
2.88%
Variação (1 ano)
-
País
CA
Negociar Cybin Inc. Common Stock (HELP)

Categoria

Healthcare
Rácio P/S de Cybin Inc. Common Stock (HELP)
Rácio P/S em 2026 TTM: 0
De acordo com os relatórios financeiros mais recentes e o preço das ações da Cybin Inc. Common Stock, o rácio P/S atual (TTM) é 0. No final de 2026, o rácio P/S era 0.
Histórico do rácio P/S da Cybin Inc. Common Stock de 2026 a 2026
Rácio P/S no final de cada ano
Ano Rácio P/S Alterar
Não há dados suficientes para as datas fornecidas.
Rácio P/S de empresas semelhantes ou concorrentes
Empresa Rácio P/S Diferença do rácio P/S País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
10.17 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
10.13 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
2.95 -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
11.28 -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH